M40 Treatment of Advanced Thyroid Cancer

Program: Meet-the-Professor Sessions
Clinical Session
Friday, March 6, 2015: 3:30 PM-4:15 PM
Room 20A (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Astra Zeneca LP

R Michael Tuttle, MD, Memorial Sloan Kettering Cancer Center, New York, NY

RMT: Ad Hoc Consultant, Genzyme Corporation, Ad Hoc Consultant, Bayer, Inc., Ad Hoc Consultant, Eisai, Member of advisory committees or review panels, Novo Nordisk, Scientific Board Member, Veracyte, Inc..